How has Gabriela Godaly's remuneration changed compared to Selectimmune Pharma's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2023
n/a
n/a
-SEK 9m
Dec 31 2022
n/a
n/a
-SEK 9m
Sep 30 2022
n/a
n/a
-SEK 12m
Jun 30 2022
SEK 265k
SEK 265k
-SEK 14m
Mar 31 2022
n/a
n/a
-SEK 16m
Dec 31 2021
n/a
n/a
-SEK 15m
Sep 30 2021
n/a
n/a
-SEK 14m
Jun 30 2021
SEK 236k
SEK 236k
-SEK 13m
Mar 31 2021
n/a
n/a
-SEK 9m
Dec 31 2020
n/a
n/a
-SEK 9m
Sep 30 2020
n/a
n/a
-SEK 8m
Jun 30 2020
SEK 14k
n/a
-SEK 8m
Compensation vs Market: Gabriela's total compensation ($USD24.78K) is below average for companies of similar size in the Swedish market ($USD229.96K).
Compensation vs Earnings: Gabriela's compensation has increased whilst the company is unprofitable.
CEO
Gabriela Godaly
1.3yrs
Tenure
SEK 265,250
Compensation
Dr. Gabriela Godaly serves as a Board Member of Selectimmune Pharma AB (publ) since 2019 and serves as its Chief Medical Officer since 2020 and as its Acting Chief Executive Officer since April 26, 2022. S...
Board Members
Name
Position
Tenure
Compensation
Ownership
Gabriela Godaly
Acting CEO
4.6yrs
SEK 265.25k
no data
Catharina Svanborg
Chairperson of the Board
6.6yrs
SEK 360.00k
40.59% SEK 16.9m
Carl-Johan Wachtmeister
Board Member
5.6yrs
no data
no data
Helena Lomberg
Board Member
6.6yrs
no data
1.29% SEK 537.2k
Magnus Nylen
Board Member
less than a year
no data
no data
5.6yrs
Average Tenure
Experienced Board: SELECT B's board of directors are considered experienced (5.6 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2023/08/11 02:11
End of Day Share Price
2023/08/08 00:00
Earnings
2023/03/31
Annual Earnings
2022/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Selectimmune Pharma AB (publ) is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.